QUOTE AND NEWS
Motley Fool  Jun 27  Comment 
Can Amarin continue to swim upstream?
Motley Fool  May 31  Comment 
Even though the stock market was mixed, these stocks gained. Find out why.
Motley Fool  May 30  Comment 
Agenus and Amarin's share prices could soar over the next year. Are these two speculative biotechs worth the risk?
Motley Fool  May 9  Comment 
The drugmaker's stock is heating up as the company approaches a pivotal clinical data readout.
Benzinga  Apr 4  Comment 
Amarin Corporation plc (NASDAQ: AMRN) today announced two posters presented yesterday at the annual meeting of the American College of Cardiology (ACC). This research adds to the growing body of clinical and pre-clinical data relevant to the use...





 



References

This is a test No its not

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki